|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.380 USD | +9.66% |
|
+52.48% | +235.45% |
| Dec. 09 | Immix Biopharma announces closing of upsized $100 million underwritten offering of common stock and pre-funded warrants | RE |
| Dec. 08 | Immix Biopharma Prices $100 Million Offering | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMMIX BIOPHARMA, INC. | Bio Therapeutic Drugs | +9.66% | +52.48% | +235.45% | +218.10% | - | 248M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- IMMX Stock
- Charts Immix Biopharma, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
